Assistant Professor, Medicine, University of Washington School of Medicine

Oncology

Dr. Brian G. Till practices Oncology. He studied medicine at University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10/19 in Research/PrimaryCare. Brian Till is a published doctor as well. He has 19 publications published. The latest was: Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601. He is registered with Medicare.

Publications

---

• Pretransplant minimal residual disease predicts survival in mantle Cell lymphoma patients undergoing autologous stem Cell transplantation in complete remission.
• Maintenance rituximab after autologous stem Cell transplantation in patients with mantle Cell lymphoma.
• Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle Cell lymphoma: SWOG S0601.
• Brentuximab vedotin administered to platinum-refractory, transplant-naïve Hodgkin Lymphoma patients can increase the proportion achieving FDG PET negative status.
• T-Cell immunotherapy: looking forward.
• Autologous transplant for relapsed follicular Lymphoma: impact of pre-transplant rituximab sensitivity.
• Specific Features Identify Patients with Relapsed or Refractory Mantle Cell Lymphoma Benefitting from Autologous Hematopoietic Cell Transplantation.
• BCNU-associated pneumonitis: portrait of a toxicity.
• Mantle Cell Lymphoma International Prognostic Index but Not Pretransplantation Induction Regimen Predicts Survival for Patients With Mantle-Cell Lymphoma Receiving Hig...
• Mathematical modeling of chimeric TCR triggering predicts the magnitude of target lysis and its impairment by TCR downmodulation.
• Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle Cell lymphoma using genetically modified autologous CD20-specific T Cells.
• Response to paclitaxel in adenoid cystic Carcinoma of the salivary glands.
• Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the Cell membrane.
• Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma.
• Treatment of lymphoma with adoptively transferred T Cells.
• Effect of remission status and induction chemotherapy regimen on outcome of autologous stem Cell transplantation for mantle Cell lymphoma.
• Optimizing adoptive polyclonal T Cell immunotherapy of lymphomas, using a chimeric T Cell receptor possessing CD28 and CD137 costimulatory domains.
• Molecular characterization of KLHL3, a human homologue of the Drosophila kelch gene.

Schools

---

• U Of Chgo Div Of Bio Sci Pritzker Sch Of Med

• Hospital University Pa

Procedures Preformed

---

• HPC Transplantation (Stem Cell Transplant)

Conditions Treated

---

• Acute Leukemia
• Anal and Rectal Cancer
• Anemia
• Basal Cell Carcinoma
• View All

Doctors Specialties

---

• Medical Oncology
• Oncology

Accepted Insurances

---

Education

---

• University of Washington
• University of Pennsylvania Health System
• University of Chicago Pritzker School of Medicine

Drug Facts

---

NPI NUMBER		1902917974
NPPES Provider LastName		TILL
NPPES Provider FirstName		BRIAN
NPPES Provider ZIPCode		981956340
NPPES Provider State		WA
Specialty Description		Medical Oncology
Total Claim Count		721.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1902917974
Last Name Of The Provider	TILL
First Name Of The Provider	BRIAN
View All

Similar Doctors

---

	Dr. Hannah M. Linden, MD This Doctor is OpenDoctor Recommended.
	Dr. Vivian G. Oehler, MD This Doctor is OpenDoctor Recommended.
	Dr. David G. Maloney, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Martin A. Cheever, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. William R. Gwin III, MD This Doctor is OpenDoctor Recommended.
	Dr. Johnnie J. Orozco, MD This Doctor is OpenDoctor Recommended.
	Dr. Kristine J. Rinn, MD This Doctor is OpenDoctor Recommended.
	Dr. Sheldon Z. Goldberg, MD This Doctor is OpenDoctor Recommended.
	Dr. Elihu H. Estey, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Bernardo H. Goulart, MD This Doctor is OpenDoctor Recommended.
	Dr. Andrew L. Coveler, MD This Doctor is OpenDoctor Recommended.
	Dr. Stanley R. Riddell, MD This Doctor is OpenDoctor Recommended.
	Dr. Shailender Bhatia, MD This Doctor is OpenDoctor Recommended.
	Dr. Jennifer M. Specht, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog